<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lack of dystrophin results in skeletal muscle <z:mpath ids='MPATH_554'>dystrophy</z:mpath> and <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> in humans and animal models </plain></SENT>
<SENT sid="1" pm="."><plain>To achieve a basic understanding of the natural development of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in different dystrophinopathy mouse models, left and right ventricular heart function was assessed at different ages in three dystrophinopathy mouse models (mdx, mdx/utrn(+/-) model and mdx/utrn(-/-)) using magnetic resonance imaging </plain></SENT>
<SENT sid="2" pm="."><plain>Left ventricular function was significantly decreased, already at 2months in the most severely affected mdx/utrn(-/-) mice </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, whereas heart function was stable in <z:mp ids='MP_0002169'>wild-type</z:mp> mice over time, both mdx and mdx/utrn(+/-) showed a clear decrease at 10months of age, most prominently in the right ventricle </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore magnetic resonance imaging is an adequate technique to determine heart function in dystrophinopathy mouse models and can be used to assess the effect of potential therapies </plain></SENT>
</text></document>